Literature DB >> 15292905

Nicotine-associated cues maintain nicotine-seeking behavior in rats several weeks after nicotine withdrawal: reversal by the cannabinoid (CB1) receptor antagonist, rimonabant (SR141716).

Caroline Cohen1, Ghislaine Perrault, Guy Griebel, Philippe Soubrié.   

Abstract

Conditioned stimuli are important for nicotine dependence and may trigger craving and relapse after prolonged nicotine abstinence. However, little is known about the pharmacology of this process. Among the systems that have been shown to play a role in drug-seeking behavior is the endocannabinoid transmission. Therefore, the present study examined the resistance to extinction of drug-seeking behavior elicited by nicotine-associated environmental stimuli and the effects of the selective CB1 cannabinoid antagonist rimonabant (SR141716) on the reinforcing effects of nicotine-related stimuli. Rats were trained to self-administer nicotine (0.03 mg/kg/injection, i.v.) under conditions in which responding was reinforced jointly by response-contingent nicotine injections and stimuli (light and tone). After self-administration acquisition, nicotine was withdrawn and lever pressing was only reinforced by contingent presentation of the audiovisual stimuli. Under such a condition, responding persisted for 3 months, following which nonpresentation of the cues produced a progressive extinction of responding. As expected, rats trained to lever-press for saline injections paired with the audiovisual stimuli did not acquire the self-administration. These findings indicate that the cues required learned association with nicotine to acquire reinforcing properties and to function as conditioned reinforcers. When administered 1 month following nicotine withdrawal, rimonabant (1 mg/kg, i.p.) decreased conditioned behavior. These results showing the persistence of a nicotine-conditioned behavior are congruent with the role of nicotine-related environmental stimuli in nicotine craving in abstinent smokers. Rimonabant, which has been shown previously to reduce nicotine self-administration, may be effective not only as an aid for smoking cessation but also in the maintenance of abstinence.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15292905     DOI: 10.1038/sj.npp.1300541

Source DB:  PubMed          Journal:  Neuropsychopharmacology        ISSN: 0893-133X            Impact factor:   7.853


  99 in total

1.  Concurrent access to nicotine and sucrose in rats.

Authors:  Leigh V Panlilio; Lee Hogarth; Mohammed Shoaib
Journal:  Psychopharmacology (Berl)       Date:  2014-11-01       Impact factor: 4.530

2.  Conditioned reinforcement in rats established with self-administered nicotine and enhanced by noncontingent nicotine.

Authors:  Matthew I Palmatier; Xiu Liu; Gina L Matteson; Eric C Donny; Anthony R Caggiula; Alan F Sved
Journal:  Psychopharmacology (Berl)       Date:  2007-08-05       Impact factor: 4.530

Review 3.  Complex interactions between nicotine and nonpharmacological stimuli reveal multiple roles for nicotine in reinforcement.

Authors:  Nadia Chaudhri; Anthony R Caggiula; Eric C Donny; Matthew I Palmatier; Xiu Liu; Alan F Sved
Journal:  Psychopharmacology (Berl)       Date:  2005-10-21       Impact factor: 4.530

4.  Effects of isoarecolone, a nicotinic receptor agonist in rodent models of nicotine dependence.

Authors:  Mohammed Shoaib
Journal:  Psychopharmacology (Berl)       Date:  2006-08-24       Impact factor: 4.530

Review 5.  Nicotine and hippocampus-dependent learning: implications for addiction.

Authors:  Thomas J Gould
Journal:  Mol Neurobiol       Date:  2006-10       Impact factor: 5.590

Review 6.  Hypothalamic regulatory pathways and potential obesity treatment targets.

Authors:  Erin E Jobst; Pablo J Enriori; Puspha Sinnayah; Michael A Cowley
Journal:  Endocrine       Date:  2006-02       Impact factor: 3.633

7.  The effect of nicotine on sign-tracking and goal-tracking in a Pavlovian conditioned approach paradigm in rats.

Authors:  Matthew I Palmatier; Kimberley R Marks; Scott A Jones; Kyle S Freeman; Kevin M Wissman; A Brianna Sheppard
Journal:  Psychopharmacology (Berl)       Date:  2012-10-23       Impact factor: 4.530

8.  The endogenous cannabinoid system modulates nicotine reward and dependence.

Authors:  Lisa L Merritt; B R Martin; C Walters; A H Lichtman; M Imad Damaj
Journal:  J Pharmacol Exp Ther       Date:  2008-05-01       Impact factor: 4.030

9.  The inverse agonist of CB1 receptor SR141716 blocks compulsive eating of palatable food.

Authors:  Riccardo Dore; Marta Valenza; Xiaofan Wang; Kenner C Rice; Valentina Sabino; Pietro Cottone
Journal:  Addict Biol       Date:  2013-04-16       Impact factor: 4.280

10.  The alpha4beta2 nicotinic acetylcholine-receptor partial agonist varenicline inhibits both nicotine self-administration following repeated dosing and reinstatement of nicotine seeking in rats.

Authors:  Eoin C O'Connor; Dale Parker; Hans Rollema; Andy N Mead
Journal:  Psychopharmacology (Berl)       Date:  2009-12-05       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.